Study of a supplement for walking ability in people with peripheral artery disease
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether a supplement called nicotinamide riboside (a form of vitamin B3) can improve walking ability in people with peripheral artery disease (PAD), a condition that causes leg pain when walking due to poor blood flow. It is a phase 3 trial, meaning it's in the final stages of testing before possible approval.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 50 years or older.
- You must have a confirmed diagnosis of peripheral artery disease (PAD), such as a low ankle-brachial index (ABI) test result.
- You must be able to walk without a walker or wheelchair and have no other condition that limits walking more than PAD.
- You must not have a current foot ulcer, critical limb ischemia (severe PAD with pain at rest), or a recent major surgery or heart event.
- You must not have taken high doses of vitamin B3 or nicotinamide riboside in the last 3 months.
- You must be willing to participate in the study and not be in another clinical trial intervention currently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether beetroot juice, which contains natural nitrates that help blood vessels relax, combined with exercise, can improve walking ability in people with peripheral artery disease (PAD). You might be able to join if you have PAD, can walk without a walker, and are willing to avoid beet products for a while.
This trial tests whether a home-based exercise program is as effective as supervised exercise for improving walking ability in people with peripheral artery disease (PAD). You will be randomly assigned to one of two exercise groups, and you may be asked to drink beetroot juice as part of the study.
This trial tests whether a drug called diroximel fumarate (Vumerity) can improve blood flow and walking ability in people with peripheral artery disease (PAD). It compares people with PAD to healthy volunteers of the same age.
This trial tests a nutritional supplement (nicotinamide riboside) to see how it affects blood flow in healthy adults. It may help understand how to support vascular health as we age.
This study tests whether a daily supplement called nicotinamide riboside (a form of vitamin B3), combined with a supervised exercise program, can help promote healthy aging and improve how well your body functions. You would take the supplement or a placebo for 12 weeks while doing light to moderate exercise.
This study tests whether a supplement called NAD (a natural substance that helps cells produce energy) can improve symptoms in people with Parkinson's disease. You would take the supplement daily for several weeks, and researchers will check your movement, thinking, and overall well-being.
Hear when a new Peripheral Artery Disease (PAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.